IBEX 35
11.057,40 -61,50 (-0,55%) Euro Stoxx 50
4.915,85 -20,12 (-0,41%) Dólar/Euro
1,0694 -0,0022 (-0,20%) Petróleo Brent
85,36 +0,35 (+0,41%) Oro
2.324,90 -5,90 (-0,25%) Bitcoin EUR
57.494,73 +279,99 (+0,49%)
MPH Health Care AG (93M1.DE)
MPH Health Care AG
Grünauer Straße 5
Berlin 12557
Germany
49 30 863 214 560
https://www.mph-ag.de
Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 2
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Patrick Brenske | CEO & Member of Management Board | N/A | N/A | N/A |
Descripción
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. The company operates Beauty, Pharma, and Real Estate segments. It offers medicalaesthetic beauty operations and treatments, as well as the operation and provision of medical infrastructures for partner companies; and pharmaceuticals and medical products in the therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company also focuses on therapies for cancer, HIV, rheumatology, and other chronic diseases. In addition, the company offers plastic and aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and specialist medical centres. In addition, it is involved in the provision of cytostatic solutions; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany.
Gobierno corporativo
El ISS Governance QualityScore de MPH Health Care AG, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
